http://www.prnewswire.com/rss/health/clinical-trials-medial-discoveries-news.rss/ Press Releases from PR Newswire about Clinical Trials & Medical Discoveries en-us Wed, 02 Oct 2013 15:46:00 EDT Wed, 02 Oct 2013 13:11:00 EDT http://www.prnewswire.com/news-releases/ophthalix-to-present-at-the-ophthalmology-futures-european-forum-226159191.html http://www.prnewswire.com/news-releases/ophthalix-to-present-at-the-ophthalmology-futures-european-forum-226159191.html Wed, 02 Oct 2013 13:11:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/klox-technologies-anuncia-la-aprobacion-en-canada-de-su-innovador-tratamiento-del-acne-vulgar-226158071.html http://www.prnewswire.com/news-releases/klox-technologies-anuncia-la-aprobacion-en-canada-de-su-innovador-tratamiento-del-acne-vulgar-226158071.html Wed, 02 Oct 2013 13:03:00 EDT es PR Newswire Association LLC. http://www.prnewswire.com/news-releases/adamas-pharmaceuticals-presenta-datos-clinicos-positivos-para-ads-5102-un-tratamiento-para-la-disquinesia-inducida-por-levodopa-en-el-congreso-mundial-del-parkinson-226143921.html http://www.prnewswire.com/news-releases/adamas-pharmaceuticals-presenta-datos-clinicos-positivos-para-ads-5102-un-tratamiento-para-la-disquinesia-inducida-por-levodopa-en-el-congreso-mundial-del-parkinson-226143921.html Wed, 02 Oct 2013 11:30:00 EDT - Los resultados de la prueba EASED fase 2/3 demuestran un incremento de aproximadamente tres horas de período de respuesta a los medicamentos sin disquinesia molesta para pacientes que toman ADS-5102 en comparación con placebo MONTREAL y EMERYVILLE, California, 2 de octubre...

]]>

]]> PRNewswire es PR Newswire Association LLC. http://www.prnewswire.com/news-releases/adamas-pharmaceuticals-presents-positive-clinical-data-for-ads-5102-a-treatment-for-levodopa-induced-dyskinesia-at-the-world-parkinsons-congress-226143931.html http://www.prnewswire.com/news-releases/adamas-pharmaceuticals-presents-positive-clinical-data-for-ads-5102-a-treatment-for-levodopa-induced-dyskinesia-at-the-world-parkinsons-congress-226143931.html Wed, 02 Oct 2013 11:30:00 EDT MONTREAL and EMERYVILLE, Calif., Oct. 2, 2013 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. presented positive results today from the Phase 2/3 EASED™ clinical trial of ADS-5102 at the World Parkinson's Congress.  ADS-5102 is Adamas' proprietary long-acting capsule formulation...

]]>

]]> PRNewswire en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/helsinn-lance-un-service-de-vente-aux-etats-unis-226132711.html http://www.prnewswire.com/news-releases/helsinn-lance-un-service-de-vente-aux-etats-unis-226132711.html Wed, 02 Oct 2013 10:02:00 EDT fr PR Newswire Association LLC. http://www.prnewswire.com/news-releases/research-shows-genetic-anti-inflammatory-defect-predisposes-children-to-lymphoma-226132241.html http://www.prnewswire.com/news-releases/research-shows-genetic-anti-inflammatory-defect-predisposes-children-to-lymphoma-226132241.html Wed, 02 Oct 2013 10:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/new-pooled-analysis-reports-pradaxa-dabigatran-etexilate-mesylate-may-be-associated-with-better-patient-outcomes-after-a-major-bleeding-event-compared-to-warfarin-226125031.html http://www.prnewswire.com/news-releases/new-pooled-analysis-reports-pradaxa-dabigatran-etexilate-mesylate-may-be-associated-with-better-patient-outcomes-after-a-major-bleeding-event-compared-to-warfarin-226125031.html Wed, 02 Oct 2013 09:11:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/gw-pharmaceuticals-announces-new-sativex-data-at-ectrims-226117431.html http://www.prnewswire.com/news-releases/gw-pharmaceuticals-announces-new-sativex-data-at-ectrims-226117431.html Wed, 02 Oct 2013 08:10:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/american-society-of-breast-surgeons-release-mammosite-breast-brachytherapy-registry-trial-final-results-226116031.html http://www.prnewswire.com/news-releases/american-society-of-breast-surgeons-release-mammosite-breast-brachytherapy-registry-trial-final-results-226116031.html Wed, 02 Oct 2013 08:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/multicell-technologies-expands-scope-of-research-agreement-for-the-treatment-of-liver-cancer-226116191.html http://www.prnewswire.com/news-releases/multicell-technologies-expands-scope-of-research-agreement-for-the-treatment-of-liver-cancer-226116191.html Wed, 02 Oct 2013 08:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/atheromed-announces-completion-of-patient-enrollment-in-the-ease-study-evaluating-the-phoenix-atherectomy-system-in-treating-pad-226111791.html http://www.prnewswire.com/news-releases/atheromed-announces-completion-of-patient-enrollment-in-the-ease-study-evaluating-the-phoenix-atherectomy-system-in-treating-pad-226111791.html Wed, 02 Oct 2013 07:03:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/klox-technologies-annonce-lapprobation-au-canada-de-son-traitement-novateur-contre-lacne-simple-226108751.html http://www.prnewswire.com/news-releases/klox-technologies-annonce-lapprobation-au-canada-de-son-traitement-novateur-contre-lacne-simple-226108751.html Wed, 02 Oct 2013 06:13:00 EDT fr PR Newswire Association LLC. http://www.prnewswire.com/news-releases/klox-technologies-announces-approval-in-canada-of-its-innovative-acne-vulgaris-treatment-226108101.html http://www.prnewswire.com/news-releases/klox-technologies-announces-approval-in-canada-of-its-innovative-acne-vulgaris-treatment-226108101.html Wed, 02 Oct 2013 06:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/helsinn-lanzara-una-organizacion-de-ventas-en-estados-unidos-226091511.html http://www.prnewswire.com/news-releases/helsinn-lanzara-una-organizacion-de-ventas-en-estados-unidos-226091511.html Wed, 02 Oct 2013 03:47:00 EDT es PR Newswire Association LLC. http://www.prnewswire.com/news-releases/genovive-esta-cambiando-la-forma-de-la-salud-personalizada-al-seguir-con-sus-esfuerzos-de-investigacion-con-harvard-226091271.html http://www.prnewswire.com/news-releases/genovive-esta-cambiando-la-forma-de-la-salud-personalizada-al-seguir-con-sus-esfuerzos-de-investigacion-con-harvard-226091271.html Wed, 02 Oct 2013 03:39:00 EDT es PR Newswire Association LLC. http://www.prnewswire.com/news-releases/durch-fortgesetzte-forschungsbemuhungen-mit-harvard-verandert-genovive-das-gesicht-der-personalisierten-medizin-226091261.html http://www.prnewswire.com/news-releases/durch-fortgesetzte-forschungsbemuhungen-mit-harvard-verandert-genovive-das-gesicht-der-personalisierten-medizin-226091261.html Wed, 02 Oct 2013 03:39:00 EDT de PR Newswire Association LLC. http://www.prnewswire.com/news-releases/-genovive-revolutionne-les-soins-de-sante-personnalises-grace-a-ses-recherches-continues-en-partenariat-avec-harvard--226091251.html http://www.prnewswire.com/news-releases/-genovive-revolutionne-les-soins-de-sante-personnalises-grace-a-ses-recherches-continues-en-partenariat-avec-harvard--226091251.html Wed, 02 Oct 2013 03:39:00 EDT fr PR Newswire Association LLC. http://www.prnewswire.com/news-releases/world-first-trial-for-tendon-repair-using-tendon-stem-cells-published-in-the-prestigious-american-journal-of-sports-medicine-226088881.html http://www.prnewswire.com/news-releases/world-first-trial-for-tendon-repair-using-tendon-stem-cells-published-in-the-prestigious-american-journal-of-sports-medicine-226088881.html Wed, 02 Oct 2013 02:22:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/moms-weight-gain-during-pregnancy-tied-to-childhood-obesity-226029351.html http://www.prnewswire.com/news-releases/moms-weight-gain-during-pregnancy-tied-to-childhood-obesity-226029351.html Tue, 01 Oct 2013 17:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/additional-results-of-global-primary-biliary-cirrhosis-study-group-analysis-to-be-presented-at-aasld-annual-meeting-226020741.html http://www.prnewswire.com/news-releases/additional-results-of-global-primary-biliary-cirrhosis-study-group-analysis-to-be-presented-at-aasld-annual-meeting-226020741.html Tue, 01 Oct 2013 16:05:00 EDT en-US PR Newswire Association LLC.